Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advised Statoil in connection with its acquisition of minority shareholding in Lundin Petroleum
Mandate

Vinge advised Statoil in connection with its acquisition of minority shareholding in Lundin Petroleum

January 18, 2016 Automotive, Mobility and Electrification

Vinge advised Statoil in connection with its acquisition of shares in Lundin Petroleum AB (publ) corresponding to approximately 12 percent of the shares and votes. The total purchase price amounted to approximately SEK 4.6 billion.
 
Statoil is an international energy company with approximately 22,000 employees and operations in 36 countries. Statoil is headquartered in Stavanger, Norway, and is listed on the New York Stock Exchange and Oslo Børs.
 
Vinge’s team consisted of Göran Nyström, Dain Hård Nevonen and Rikard Lindahl.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026